Protocols to investigate the drug as an early outpatient treatment for COVID-19 and as a pre-exposure prophylaxis (PrEP) followed shortly thereafter.Īt the same time, we designed and built databases for electronic data capture for these three outpatient trials. Within 8 days we had drafted and received IRB approval for a protocol to investigate hydroxychloroquine as a possible prophylaxis for those who had been recently exposed to the virus. Our team of researchers quickly prioritized our efforts and resources to respond to the public health crisis. The novelty of this disease and its level of impact required immediate and rapid research to test options for mitigation, including clinical trials of potential prophylaxis and treatment. The coronavirus disease 2019 (COVID-19) was declared a global pandemic by the WHO on March 11, 2020.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |